Scienmag
MARCH 5, 2021
Evolutionary Anthropology Quantitative real-time polymerase chain reaction (qPCR) is the most widely used diagnostic method to detect RNA viruses such as SARS-CoV-2. However, it requires expensive laboratory equipment and global shortages of reagents […].
Roots Analysis
AUGUST 16, 2023
mRNA has completely revolutionized the field of medicine and significantly influenced the study and treatment of human diseases. In the foreseen future, as more of such RNA-based leads mature and move into the clinic and / or get commercialised, we anticipate the mRNA synthesis and manufacturing services market to witness healthy growth.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Roots Analysis
FEBRUARY 21, 2022
Advancement in DNA sequencing technologies have resulted in noteworthy developments in various healthcare-related research fields, such as diagnostics and personalized medicine. Moreover, the manual protocols require extensive manipulation, costly reagents and long duration of skilled genomic library production.
Pharmaceutical Technology
FEBRUARY 15, 2023
The swift development and deployment of messenger-RNA (mRNA) vaccines against the SARS-CoV-2 virus during the COVID-19 crisis has catapulted the pharmaceuticals industry into a new paradigm. RNA has the potential to underpin breakthrough treatments for a wide variety of diseases, including many cancers, and transform medicine as we know it.
Drug Discovery World
DECEMBER 28, 2022
The Breath Biopsy VOC Atlas is a catalogue of validated and quantitated volatile organic compounds (VOCs) found on breath, designed to assist in the development of biomarkers and precision medicines. . Gyrolab Human Cytokine Kit Reagents are the first in a range of new biomarker kits from Gyros Protein Technologies. .
Drug Discovery World
DECEMBER 23, 2022
GenScript USA has expanded its global current Good Manufacturing Practices (cGMP) single-guide RNA (sgRNA) manufacturing capabilities to meet the growing demand for cell and gene therapies. . The 400,000 square-foot cGMP facility enables gene and cell therapy R&D programmes to advance IND filings and clinical trials.
The Pharma Data
MARCH 20, 2021
The Challenge: The demands of many labs simultaneously beginning COVID-19 screening programs are leading to a scarcity of resources like pipette tips and reagents. Medicine in Oxford, Biogazelle, a biotechnology company in Ghent, and the Centre For Proteome Research at the University of Liverpool. delays where reagents are in.
Expert insights. Personalized for you.
94 
Let's personalize your content